Paulo Paixão

Universidade de Lisboa

H指数:18

被引数:1,039

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of Metrics for Investigating Bioequivalence in Onset of Action in Incurred Bioequivalence Studies

关于在已实施生物等效性研究中探究起效时间生物等效性指标的比较

Pharmaceutics

IF5.5

2026-08-110

The microevolutionary trajectory of endemic multidrug-resistant tuberculosis strains in Portugal toward increased drug resistance levels and its clinical significance

Frontiers in Microbiology

IF4.5

2026-01-210

OAAI

The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the sixth international EUFEPS/PQRI conference

全球生物等效性协调倡议（GBHI）：第六届国际EUFEPS/PQRI会议报告

European Journal of Pharmaceutical Sciences

IF4.7

2025-05-140

Optimal dosing of amoxicillin in obese and post-gastric bypass patients using a population pharmacokinetics-pharmacodynamics model approach

使用群体药代动力学-药效学模型方法优化肥胖及胃 bypass 术后患者的阿莫西林最佳剂量

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2025-05-130

PRE

Physiologically Based Biopharmaceutics Model of Apixaban for Biopharmaceutics Risk Assessment

基于生理学的阿哌沙班生物药剂学模型用于生物药剂学风险评估

PHARMACEUTICS

IF5.5

2025-03-180

Infliximab in Inflammatory Bowel Disease: Leveraging Physiologically Based Pharmacokinetic Modeling in the Clinical Context

英夫利昔单抗在炎症性肠病中的应用: 在临床环境中利用基于生理的药代动力学模型

BIOMEDICINES

IF3.9

2024-09-011

OAAI

A Two-Way Proposal for the Determination of Bioequivalence for Narrow Therapeutic Index Drugs in the European Union

PHARMACEUTICS

IF5.5

2024-04-281

OAAI

The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conference

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2023-11-015

Clinical Pharmacology of Vinpocetine: Properties Revisited and Introduction of a Population Pharmacokinetic Model for Its Metabolite, Apovincaminic Acid (AVA)

PHARMACEUTICS

IF5.5

2023-10-205

OAAI

Predictive Potential of Cmax Bioequivalence in Pilot Bioavailability/Bioequivalence Studies, through the Alternative f2 Similarity Factor Method

PHARMACEUTICS

IF5.5

2023-10-201

OAAI

Alternative Analysis Approaches for the Assessment of Pilot Bioavailability/Bioequivalence Studies

PHARMACEUTICS

IF5.5

2023-05-074

OAAI

Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY

IF3

2023-01-1112

Evaluation of a Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union

PHARMACEUTICS

IF5.5

2022-10-313

OAAI

Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars

PHARMACEUTICS

IF5.5

2022-08-2412

OAAI

A Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2021-11-035

PREAI

Pharmacokinetics of amoxicillin in obese and nonobese subjects

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2021-02-1012

OAAI

Unraveling the behavior of oral drug products inside the human gastrointestinal tract using the aspiration technique: History, methodology and applications

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2020-12-0124

OAAI

In Vitro Antimicrobial Activity of Isopimarane-Type Diterpenoids

异亚胺型二萜类化合物的体外抗菌活性

MOLECULES

IF4.6

2020-09-165

OAAI

A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP

PHARMACEUTICS

IF5.5

2020-01-1746

OAAI

Reduced bioavailability of oral amoxicillin tablets compared to suspensions in Roux-en-Y gastric bypass bariatric subjects

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2019-07-1212

OAAI

Paulo Paixão

个人简介

教育背景

工作经历

荣誉奖项

研究方向